Literature DB >> 9509761

Immunodominant minor histocompatibility antigens: the major ones.

C Perreault1, D C Roy, C Fortin.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9509761     DOI： 10.1016/s0167-5699(97)01185-7

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  11 in total

1.  Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides.

Authors:  Daniel Gebreselassie; Hans Spiegel; Stanislav Vukmanovic
Journal:  Hum Immunol       Date:  2006-09-20       Impact factor: 2.850

2.  Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

Authors:  C J Wu; X F Yang; S McLaughlin; D Neuberg; C Canning; B Stein; E P Alyea; R J Soiffer; G Dranoff; J Ritz
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers.

Authors:  D P Granados; A Rodenbrock; J-P Laverdure; C Côté; O Caron-Lizotte; C Carli; H Pearson; V Janelle; C Durette; E Bonneil; D C Roy; J-S Delisle; S Lemieux; P Thibault; C Perreault
Journal:  Leukemia       Date:  2016-02-09       Impact factor: 11.528

4.  Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.

Authors:  Jean Kwun; Subramaniam Malarkannan; William J Burlingham; Stuart J Knechtle
Journal:  J Immunol       Date:  2011-09-07       Impact factor: 5.422

5.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

Authors:  Stephen C Jones; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Prediction of graft-versus-host disease in humans by donor gene-expression profiling.

Authors:  Chantal Baron; Roland Somogyi; Larry D Greller; Vincent Rineau; Peter Wilkinson; Carolyn R Cho; Mark J Cameron; David J Kelvin; Pierre Chagnon; Denis-Claude Roy; Lambert Busque; Rafick-Pierre Sékaly; Claude Perreault
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

7.  A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

Authors:  H Dolstra; H Fredrix; F Maas; P G Coulie; F Brasseur; E Mensink; G J Adema; T M de Witte; C G Figdor; E van de Wiel-van Kemenade
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

8.  Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.

Authors:  Kang Il Yoo; Ji Yeong Jeon; Su Jeong Ryu; Giri Nam; Hyewon Youn; Eun Young Choi
Journal:  Exp Mol Med       Date:  2015-02-13       Impact factor: 8.718

9.  Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.

Authors:  Denis Claude Roy; Sylvie Lachance; Sandra Cohen; Jean-Sébastien Delisle; Thomas Kiss; Guy Sauvageau; Lambert Busque; Imran Ahmad; Lea Bernard; Nadia Bambace; Radia S Boumédine; Marie-Claude Guertin; Katayoun Rezvani; Stephan Mielke; Claude Perreault; Jean Roy
Journal:  Br J Haematol       Date:  2019-05-28       Impact factor: 6.998

Review 10.  H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.

Authors:  Eun Young Choi; Kyungho Choi; Giri Nam; Woojin Kim; Minho Chung
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.